Newspaper advertisement for giving notice for the purpose of transfer of unclaimed dividend and corresponding equity shares of the Company to IEPFA.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jenburkt Pharmaceuticals has published a notice in The Free Press Journal (English) and Navshakti (Marathi) on June 3, 2025, informing shareholders about a proposed transfer of unclaimed dividends and their corresponding equity shares to the Investor Education and Protection Fund (IEPF) Authority. This action is taken under Section 124(6) of the Companies Act, 2013, and applies to shareholders who have not claimed their dividends for seven or more consecutive years. The company had already sent individual notices to the affected shareholders on June 2, 2025, giving them until September 6, 2025, to claim their dues. If no claim is received by this deadline, the shares will be moved to the IEPF Authority's demat account along with the unclaimed dividend amount. Affected shareholders can later reclaim their shares by submitting E-form IEPF-5 on the MCA website.
This is a routine regulatory compliance filing and does not impact the company's operations or stock price. Only shareholders with unclaimed dividends for 7+ years are affected, and they can still reclaim their shares by filing IEPF-5; other shareholders remain unaffected.